New genes and models for inflammatory bowel disease

点击翻译按钮获取中文摘要

Inflammatory bowel disease affecting millions of people world-wide and results in a significant economic burden ($100M in Australia per year). In collaboration with Australia’s largest biotechnology company, CSL, we will use a novel approach to discover the causes of inflammatory bowel disease. This work will lead to the development of new animal models of inflammatory bowel disease that are vital for analysing the disease and testing treatment options. In addition, this work may lead to new approaches to treating this disease. The project will result in a greater understanding of inflammatory bowel disease, the training of highly skilled scientists and potentially lead to economically valuable knowledge.